Olowofela Abimbola, Isah Ambrose O
Department of Medicine, University of Benin Teaching Hospital, Clinical Pharmacology and Therapeutics Unit, Benin City, Edo State, Nigeria.
Niger Med J. 2017 May-Jun;58(3):107-113. doi: 10.4103/nmj.NMJ_131_16.
The Nigerian hypertension guideline (2005) was based on 1999 ISH/WHO and the 2003 Sub-Saharan Africa hypertension guidelines. The changes in the prescribing pattern of physicians before and following the introduction of these guidelines as well as physicians' awareness of the guidelines in Southern Nigeria are unknown.
A retrospective study of antihypertensive prescriptions and a cross-sectional descriptive study of the physicians' awareness of the guidelines. The study was carried out at a tertiary health facility in Southern Nigeria and reviewed the case records (1999-2008) of 3379 hypertensive patients who had attended the medical outpatient clinic; it also assessed the awareness of 48 postregistration doctors working in the same hospital using a self-administered questionnaire.
Calcium channel blockers were the most prescribed class over the entire period (44.7%-69.2%) while angiotensin-converting enzyme inhibitors prescriptions increased by 325% (11.8%-51.5%). Annual prescriptions of diuretics increased steadily from 38% in 1999 to a peak of 58% in 2005. A total of 37/48 doctors responded, and a high proportion (32/37; 86.5%) were aware of the national guidelines, but only 13/37 (35.1%) were satisfied with the recommendations. Diuretics were stated as the most preferred class of antihypertensive medicines by 26/37 (70.3%) of respondents.
The findings suggest disconnect in the prescribers' knowledge of recommendations in the guidelines, their stated preferences for medicines, and the observed findings in the case records. This may be due in part to the observed dissatisfaction of doctors with the guidelines.
尼日利亚高血压指南(2005年)基于1999年国际高血压学会/世界卫生组织以及2003年撒哈拉以南非洲高血压指南制定。在这些指南引入前后医生处方模式的变化以及尼日利亚南部医生对这些指南的知晓情况尚不清楚。
一项关于抗高血压药物处方的回顾性研究以及一项关于医生对指南知晓情况的横断面描述性研究。该研究在尼日利亚南部的一家三级医疗机构开展,回顾了3379例到内科门诊就诊的高血压患者的病例记录(1999 - 2008年);还使用一份自填式问卷评估了在同一家医院工作的48名注册后医生的知晓情况。
在整个研究期间,钙通道阻滞剂是处方量最多的类别(44.7% - 69.2%),而血管紧张素转换酶抑制剂的处方量增加了325%(从11.8%增至51.5%)。利尿剂的年处方量从1999年的38%稳步上升至2005年的峰值58%。共有37/48名医生做出回应,其中很大一部分(32/37;86.5%)知晓国家指南,但只有13/37(35.1%)对指南建议感到满意。26/37(70.3%)的受访者表示利尿剂是最常用的抗高血压药物类别。
研究结果表明,处方者对指南中建议的了解、他们对药物的明确偏好以及病例记录中的观察结果之间存在脱节。这可能部分归因于观察到医生对指南的不满。